Sector Gamma As Bio Rad Laboratories, Inc. Transaction History

Sector Gamma As

$297 Million
Q1 2025

A detailed history of Sector Gamma As transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Sector Gamma As holds 13,829 shares of BIO stock, worth $3.5 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

13,829

Previous 16,829 17.83%

Holding current value

$3.5 Million

Previous $5.53 Million 39.07%

% of portfolio

1.13%

Previous 2.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$243.0 - $367.0 $729,000 - $1.1 Million	-3,000 Reduced 17.83%	13,829 $3.37 Million
Q2 2024 Aug 09, 2024	SELL	$268.26 - $339.48 $4.52 Million - $5.71 Million	-16,833 Reduced 50.01%	16,829 $4.6 Million
Q1 2024 May 08, 2024	BUY	$304.11 - $351.99 $3.06 Million - $3.54 Million	10,053 Added 42.58%	33,662 $11.6 Million
Q4 2023 Feb 05, 2024	BUY	$269.37 - $365.04 $6.36 Million - $8.62 Million	23,609 New	23,609 $7.62 Million
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $992,713 - $1.19 Million	-2,371 Reduced 14.83%	13,617 $6.52 Million
Q4 2022 Feb 07, 2023	BUY	$351.71 - $456.01 $1.41 Million - $1.82 Million	4,000 Added 33.37%	15,988 $6.72 Million
Q3 2022 Nov 09, 2022	BUY	$412.59 - $563.26 $83,755 - $114,341	203 Added 1.72%	11,988 $5 Million
Q2 2022 Aug 05, 2022	SELL	$463.67 - $597.16 $463,670 - $597,160	-1,000 Reduced 7.82%	11,785 $5.83 Million
Q1 2022 May 06, 2022	BUY	$524.57 - $735.42 $601,157 - $842,791	1,146 Added 9.85%	12,785 $7.2 Million
Q4 2021 Feb 08, 2022	BUY	$708.84 - $794.68 $272,194 - $305,157	384 Added 3.41%	11,639 $8.79 Million
Q3 2021 Oct 29, 2021	SELL	$657.71 - $825.77 $3.21 Million - $4.03 Million	-4,881 Reduced 30.25%	11,255 $8.4 Million
Q2 2021 Aug 04, 2021	SELL	$576.64 - $649.04 $1.97 Million - $2.22 Million	-3,421 Reduced 17.49%	16,136 $10.4 Million
Q1 2021 May 10, 2021	SELL	$547.01 - $662.35 $1.02 Million - $1.23 Million	-1,860 Reduced 8.68%	19,557 $11.2 Million
Q4 2020 Feb 10, 2021	SELL	$510.68 - $643.45 $2.06 Million - $2.6 Million	-4,035 Reduced 15.85%	21,417 $12.5 Million
Q3 2020 Nov 09, 2020	SELL	$454.43 - $535.6 $371,723 - $438,120	-818 Reduced 3.11%	25,452 $13.1 Million
Q2 2020 Aug 07, 2020	SELL	$334.87 - $493.06 $2.08 Million - $3.06 Million	-6,200 Reduced 19.09%	26,270 $11.9 Million
Q1 2020 May 11, 2020	SELL	$320.01 - $409.07 $3.97 Million - $5.07 Million	-12,400 Reduced 27.64%	32,470 $11.4 Million
Q4 2019 Feb 12, 2020	SELL	$319.73 - $374.2 $478,955 - $560,551	-1,498 Reduced 3.23%	44,870 $16.6 Million
Q3 2019 Nov 05, 2019	SELL	$304.55 - $345.24 $11.8 Million - $13.3 Million	-38,658 Reduced 45.47%	46,368 $15.4 Million
Q2 2019 Jul 31, 2019	SELL	$286.93 - $312.59 $680,311 - $741,150	-2,371 Reduced 2.71%	85,026 $26.6 Million
Q1 2019 May 13, 2019	SELL	$224.3 - $317.41 $2.09 Million - $2.95 Million	-9,300 Reduced 9.62%	87,397 $26.7 Million
Q3 2018 Nov 15, 2018	BUY	$289.28 - $326.15 $11.9 Million - $13.4 Million	41,183 Added 74.18%	96,697 $30.3 Million
Q3 2018 Nov 08, 2018	SELL	$289.28 - $326.15 $8.95 Million - $10.1 Million	-30,935 Reduced 35.78%	55,514 $17.4 Million
Q2 2018 Aug 02, 2018	SELL	$244.1 - $303.88 $1.9 Million - $2.37 Million	-7,791 Reduced 8.27%	86,449 $24.9 Million
Q1 2018 May 09, 2018	SELL	$233.97 - $274.11 $187,176 - $219,288	-800 Reduced 0.84%	94,240 $23.6 Million
Q4 2017 Feb 12, 2018	SELL	$216.94 - $271.3 $3.12 Million - $3.91 Million	-14,400 Reduced 13.16%	95,040 $22.7 Million
Q3 2017 Nov 07, 2017	SELL	$212.27 - $242.28 $1.17 Million - $1.33 Million	-5,502 Reduced 4.79%	109,440 $24.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	114,942	114,942 $26 Million

Others Institutions Holding BIO

# of Institutions

449

Shares Held

18.7M

Call Options Held

12.7K

Put Options Held

14.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.24B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.

Account